tbuckley/cabot-search huggingface dataset:
Neural Network Diagnoses the Antiphospholipid Syndrome without Interrupting Anticoagulant Therapy
Authors: Romy de Laat-Kremers, Denis Wahl, Stéphane Zuily, Marisa Ninivaggi, Veronique Regnault, Jacek Musial, Philip G. de Groot, Katrien Devreese, Bas de Laat
Journal: Blood (2022)
High Molecular Response Rate and Overall Survival with <i>FLT3</i> Inhibitors As MRD-Guided Salvage Treatment for Molecular Failure in AML
Authors: Jad Othman, Nicola Potter, Katya Mokretar, David Taussig, Anjum Khan, Pramila Krishnamurthy, Anne-Louise Latif, Paul Cahalin, James Aries, Mariam Amer, Edward Belsham, Eibhlin Conneally, Charles Craddock, Dominic Culligan, Mike Dennis, Caroline Duncan, Caroline Furness, Paraskevi Gkreka, Katherine Hodgson, Wendy Ingram, Andrew King, Panagiotis Kottaridis, Mary Frances McMullin, Unmesh Mohite, Loretta Ngu, Katharine Patrick, Tom Rider, Wing Roberts, Marianne Tang Severinsen, Neill Storrar, Tom Taylor, Nigel H. Russell, Richard Dillon
Journal: Blood (2022)
Mortality of COVID-19 in Patients with Hematological Malignancies Versus Solid Tumors: A Systematic Literature Review and Meta-Analysis
Authors: Charan Thej Reddy Vegivinti, Tejo Niharika Musunuru, Sahas Reddy Jitta, Mansi Mehta, Jeevan Shivkumar, Rahul Kumar Thakur, Praneeth Reddy Keesari, Yashwitha Sai Pulakurthi, Nicole Hardy, Jade Thurnham, Alexander Mebane, John Pederson, Ranita Tarchand, Peace Olanirann, Kevin Kallmes
Journal: Blood (2022)
Adult T-Cell Leukemia/Lymphoma Diagnosed in North American Is Characterized By a Requirement for BCL6 and a Cell Cycle Program Associated with DNA Replication Stress
Authors: B. Hilda Ye, Elaine Chung, Xiaoxin Ren, Kith Pradhan, Yanhua Wang, Advaitha Madireddy, Xingxing Zang, Murali Janakiram, R. Alejandro Sica, Amit Verma
Journal: Blood (2022)
IRAK1 Contributes to IRAK4 Inhibitor Resistance Via Non-Canonical Signaling Mechanisms in MDS/AML
Authors: Josh Bennett, Jennifer Yeung, Avery Sampson, Kathleen Hueneman, Mark Wunderlich, Kwangmin Choi, Andrew Volk, Scott B. Hoyt, Craig J. Thomas, Daniel T. Starczynowski
Journal: Blood (2022)
Aging-Related Gene Expression Signatures Define Likelihood of Disease Progression in Patients with Lower-Risk Myelodysplastic Syndromes
Authors: Monika Kaisrlikova, Iva Trsová, Zuzana Lenertova, Jitka Vesela, David Kundrat, Hana Votavova, Michaela Dostalova Merkerova, Zdenek Krejcik, Martin Vostry, Jaroslav Cermak, Monika Belickova
Journal: Blood (2022)
Interferon-α-2b As a Maintenance Therapy Gain a High Rate of MRD Negative Conversion and Improve RFS in Patients with Favorable-Risk Acute Myeloid Leukemia----a Prospective, Single-Arm Study
Authors: Xiaohong Liu, Yao Li, Wenjing Yu, Xiaolu Zhu, Jinsong Jia, Lizhong Gong, Xiaosu Zhao, Yingjun Chang, Xiao-Jun Huang, Hao Jiang
Journal: Blood (2022)
Exploratory Results of PET-CT and Residual Lymph Node Fine Needle Aspiration of Patients Treated with First-Line Venetoclax and Ibrutinib for CLL/Sll; First Interim Analysis of the Phase 2 HOVON 158/Next STEP Trial
Authors: Mark-David Levin, Sabina Kersting, Julie M.N. Dubois, Yvette Norden, Johan A Dobber, Yvonne W.S. Jauw, Anne-Marie van der Kevie-Kersemaekers, Clemens Mellink, Koen de Heer, Leonie van der Burg, Doreen Te Raa, Fransien de Boer, Jolanda Droogendijk, Cecile Idink, Marten R. Nijziel, Lidwine W. Tick, Inge Ludwig, Matthijs Silbermann, Aart Beeker, Mar Bellido, Ludo M. Evers, Gerben JC Zwezerijnen, Carsten U Niemann, Arnon P. Kater
Journal: Blood (2022)
Novel First-in-Class Drug ONC201 As a Post-Transplant Maintenance for AML and MDS: A Phase I Trial in Progress
Authors: Vijaya Raj Bhatt, Christopher Wichman, Alyssa C. Bouska, Lori Maness, Zaid S. Al-Kadhimi, Javeed Iqbal, James E. Talmadge, Krishna Gundabolu
Journal: Blood (2022)
Chronic Lymphocytic Leukemia in African Ancestry Population Is Characterized By Increased Telomere Erosion
Authors: Cecilia Bonolo De Campos, Chantal McCabe, Laura Ann Bruins, Daniel R. O'Brien, Sochilt Brown, Cristine Allmer, Yuan Xiao Zhu, Kari G Rabe, Sameer A. Parikh, Neil E. Kay, James R. Cerhan, Laura Z Rassenti, Richard R. Furman, J. Brice Weinberg, Danielle Brander, Marta Chesi, Susan L. Slager, Esteban Braggio
Journal: Blood (2022)
Survival and Outcomes after Relapse in Newly Diagnosed Acute Myeloid Leukemia (AML) Patients Treated with Venetoclax-Based Chemotherapy
Authors: Lydia D Chow, Denaly Chen, Maria E. Vergara-Lluri, Eric Tam, Karrune Woan, Preet M. Chaudhary, George Yaghmour, Abdullah Ladha
Journal: Blood (2022)
Viral Reactivation and Immune Reconstitution after CAR-T Cell Treatment in Patients with Hematologic Malignancies
Authors: Ameya Shrinivas Kunte, Nico Gagelmann, Anita Badbaran, Carolina Berger, Radwan Massoud, Evgeny Klyuchnikov, Christine Wolschke, Dietlinde Janson, Ulrike Fritsche-Friedland, Boris Fehse, Nicolaus Kroeger, Francis A. Ayuk
Journal: Blood (2022)
Single-Cell Transcriptome Reveals Comprehensive Immune Profiles of T Follicular Helper Cell Lymphoma
Authors: Sakurako Suma, Manabu Fujisawa, Yoshiaki Abe, Yasuhito Suehara, Daisuke Kaji, Takeshi Sugio, Koji Kato, Koichi Akashi, Kosei Matsue, Naoya Nakamura, Ayako Suzuki, Yutaka Suzuki, Shigeru Chiba, Mamiko Sakata-Yanagimoto
Journal: Blood (2022)
Short Telomere Syndromes and Inherited Predisposition to Bone Marrow Diseases: The MDACC Experience
Authors: Alex Bataller, Yoheved Gerstein, Naveen Pemmaraju, Danielle Hammond, Hussein A. Abbas, Ghayas C. Issa, Koichi Takahashi, Tapan M. Kadia, Guillermo Garcia-Manero, Farhad Ravandi, Hagop Kantarjian, Courtney D. DiNardo
Journal: Blood (2022)
Immunogenicity of Covid-19 Vaccine Among Multiple Myeloma Patients Post Autologous Stem Cell Transplant
Authors: Nishanth Thalambedu, Yetunde Ogunsesan, Jaskirat Sethi, Munawwar Hussain, Lakshmi Yarlagadda, Sravani Gundarlapalli, Horace J. Spencer, Clyde Bailey, Samer Al Hadidi, Sharmilan Thanendrarajan, Maurizio Zangari, John D. Shaughnessy, Fenghuang Zhan, Juan Carlos Rico Crescencio, Frits van Rhee, Carolina Schinke
Journal: Blood (2022)
Preliminary Safety and Efficacy of Relmacabtagene Autoleucel (relma-cel) in Adults with Relapsed/Refractory Mantle Cell Lymphoma (r/r MCL) in China
Authors: Zhitao Ying, Keshu Zhou, Lanfang Li, Wenyu Li, Su Yang, Yun Liu, Yongen Gu, Zisong Zhou, Alex Tian, Yuqin Song, Jun Zhu
Journal: Blood (2022)
Assessment of Concurrent Personal and Family History of Hematologic Malignancies in Patients Referred for Genetic Counseling at Thomas Jefferson University Hospital (TJUH), Sidney Kimmel Cancer Center (SKCC) from 2014-2021
Authors: Molly Halloran, Gina Keiffer, Veda Giri, Laura Gross, Lindsay Wilde, Neil Palmisiano, Pierluigi Porcu, Margaret Kasner
Journal: Blood (2022)
Predictors of Disease Progression and Survival in Patients with Myelodysplastic Syndrome Secondary to Inherited Bone Marrow Failure Syndromes
Authors: Reena Pabari, Elisa Cohen, Geoff D.E. Cuvelier, Robert J. Klaassen, Stephanie Villeneuve, Josee Brossard, Sharon Abish, MacGregor Steele, Yves D. Pastore, Jeffrey H. Lipton, Meera Rayar, Vicky R. Breakey, Laura Wheaton, Lawrence Jardine, Roona Sinha, Lisa Goodyear, Bruno Michon, Catherine Corriveau-Bourque, Lillian Sung, Yigal Dror, Michaela Cada
Journal: Blood (2022)
A Propensity Score-Adjusted Comparison of Lenalidomide + R-CHOP Versus R-CHOP for <i>MYC</i>-Rearranged DLBCL Patients
Authors: A. Vera de Jonge, Erik D. van Werkhoven, Avinash G. Dinmohamed, Marcel Nijland, Aeilko H. Zwinderman, Patrick M. Bossuyt, Martine S. Veldhuis, Emma G.G.M. Rutten, Rogier Mous, Joost S.P. Vermaat, Yorick Sandberg, Eva de Jongh, Yavuz M. Bilgin, Rinske Boersma, Harry R. Koene, Marie Jose Kersten, Daphne de Jong, Martine E.D. Chamuleau
Journal: Blood (2022)
Clinical Impact of the Intensity of Induction Regimens Prior to Consolidation in Treatment-Naïve Patients with Peripheral T-Cell Lymphoma (PTCL)
Authors: Muhammad Salman Faisal, Gabrielle Hartman, Arya Roy, Andrea Anampa-Guzman, Sheeba Ba Aqeel, Hassan Awada, Matthew J Cortese, Pallawi Torka, Suchitra Sundaram, Paola Ghione
Journal: Blood (2022)
Booster Dose of mRNA-Based COVID-19 Vaccine Induces a Humoral and Cellular Response in Patients Recently Treated with Anti-CD20 Monoclonal Antibodies
Authors: Masashi Nishikubo, Yoshimitsu Shimomura, Ryusuke Yamamoto, Hayato Maruoka, Seiko Nasu, Tomomi Nishioka, Kenji Sakizono, Satoshi Mitsuyuki, Tomoyo Kubo, Naoki Okada, Daishi Nakagawa, Kimimori Kamijo, Hiroharu Imoto, Yuya Nagai, Nobuhiro Hiramoto, Satoshi Yoshioka, Noboru Yonetani, Tadakazu Kondo, Takayuki Ishikawa
Journal: Blood (2022)
Predictive Value of Staging PET/CT to Detect Bone Marrow Involvement in Marginal Zone Lymphoma (MZL): An Analysis from LEO MZL Working Group
Authors: Juan Pablo Alderuccio, Isildinha M Reis, Jean L. Koff, Melissa C. Larson, Dai Chihara, Wei Zhao, Sara Haddadi, Thomas M. Habermann, Peter Martin, Jennifer R Chapman-Fredricks, Christopher Strouse, Brad S. Kahl, Jonathon B. Cohen, Jonathan W. Friedberg, James R. Cerhan, Christopher R. Flowers, Izidore S. Lossos
Journal: Blood (2022)
Single-Cell Multi-Omics Analysis Reveals the Role of CX3CR1+ GNLY+ CD8+ T Cells in Improving Survival of Patients with Relapse/Refractory Hematologic Malignancies after Haplo+Cord HSCT
Authors: Hua Li, Zheyang Zhang, Ming Zhu, Xiaofan Li, Tao Chen, Yuanzhong Chen, Jialiang Huang, Nainong Li
Journal: Blood (2022)
Phase 1 Dose Escalation Trial of Pegcrisantaspase in Combination with Venetoclax in Adults with Relapsed or Refractory Acute Myeloid Leukemia
Authors: Dominique R Bollino, Yuchen Liu, Osman Mohamed Bah, Katherine Caprinolo, Jinoos Zarrabi, Sunita Philip, Ezzat Mostafa, Rena G. Lapidus, Zeba Singh, Michael Kallen, Yi Ning, Rima Koka, Maria R. Baer, Sandrine Niyongere, Vu H. Duong, Erin T Strovel, Molly Graveno, Ashkan Emadi
Journal: Blood (2022)
Activity of Azacitidine and Venetoclax Compared to Other Therapies in Adults with Refractory or Relapsed Acute Myeloid Leukemia, a Retrospective Study
Authors: Andree-Anne Pelland, Xavier Savard, Frederic Barabe, Vincent Laroche, Michaël Munger, Genevieve Gallagher, Nicolas Marcoux, Guy Cantin, Maxime Chénard-Poirier, Robert Delage, Marc Lalancette, Christopher Lemieux
Journal: Blood (2022)
Oncometabolite-Independent Anti-Apoptotic Feature Via Phospholipid Metabolic Adaptation in <i>IDH2</i> Mutant AML Cells
Authors: Tatsuya Morishima, Koichi Takahashi, Desmond Wai Loon Chin, Kenji Tokunaga, Yuichiro Arima, Masao Matsuoka, Toshio Suda, Hitoshi Takizawa
Journal: Blood (2022)
Cytomegalovirus (CMV) Reactivation within in the First Year after Chimeric Antigen Receptor (CAR) T Cell Therapy: Experience from the First Two Years at a Major Cancer Center
Authors: Fareed Khawaja, Rishab Prakash, Joseph Sassine, Guy Handley, Tracy VanWieren, Georgios Angelidakis, Swaminathan P. Iyer, Jeremy L. Ramdial, Sairah Ahmed, Yago Nieto, Amy Spallone, Ella J. Ariza-Heredia, Roy Chemaly
Journal: Blood (2022)
Phase I Study of Ixazomib with Conventional Chemotherapy in the Treatment of Acute Myeloid Leukemia in Older Adults
Authors: Philip C. Amrein, Eyal C. Attar, Geoffrey G Fell, Traci M. Blonquist, Andrew M. Brunner, Gabriela S. Hobbs, Hanno R. Hock, Steven McAfee, Rupa Narayan, Jenna A. Moran, Meghan Bergeron, Julia E. Foster, Christina Bertoli, Kristin McGregor, Meghan Burke, Tanya T. Behnan, Tina T. Som, Aura Y. Ramos, Megan K. Vartanian, Jennifer Lombardi Story, Donna S. Neuberg, Amir T. Fathi
Journal: Blood (2022)
CFT7455, a Novel IKZF1/3 Degrader, Demonstrates Potent Anti-Tumor Activity in Models of Non-Hodgkin's Lymphoma As a Single Agent or in Combination with Clinically Approved Agents
Authors: Samantha Perino, R. Jason Kirby, Roman Agafonov, Prasoon Chaturvedi, Scott Eron, Andrew Good, Ashley Hart, Minsheng He, Riadh Lobbardi, Andrew J Phillips, David Proia, James Henderson, Michael Thomeius, Christopher Nasveschuk, Stewart L Fisher, Roy Macfarlane Pollock
Journal: Blood (2022)
Efficacy and Safety of Single-Agent Zandelisib Administered By Intermittent Dosing in Patients with Relapsed or Refractory (R/R) Follicular Lymphoma (FL): Final Results of the Tidal Phase 2 Study
Authors: Andrew D. Zelenetz, Wojciech Jurczak, Vincent Ribrag, Kim M. Linton, Graham P. Collins, Mark Bishton, Javier López Jiménez, Bhagirathbhai Dholaria, Andrea Mengarelli, Tycel J. Phillips, Nagendra Prasad Sungala, Henry Chan, Gerardo Musuraca, Oonagh Sheehy, Junyi Yan, Weiming Xu, Michel Azoulay, Pier Luigi Zinzani
Journal: Blood (2022)
Efficacy and Safety of Luspatercept in Adult Patients with Transfusion-Dependent Anemia Due to Very Low, Low and Intermediate Risk Myelodysplastic Syndromes (MDS) with Ring Sideroblasts, Who Had an Unsatisfactory Response to or Are Ineligible for Erythropoietin-Based Therapy: A Retrospective Multicenter Study By Fondazione Italiana Sindromi Mielodisplastiche (FiSiM ETS)
Authors: Luca Lanino, Prassede Salutari, Alessandra Perego, Bruno Fattizzo, Marta Riva, Marta Ubezio, Pellegrino Musto, Daniela Cilloni, Esther Natalie Oliva, Maria Teresa Voso, Anna Maria Pelizzari, Antonella Poloni, Isabella Capodanno, Chiara Elena, Claudio Fozza, Fabrizio Pane, Massimo Breccia, Marco De Gobbi, Francesco Di Bassiano, Daniela Barraco, Elena Crisà, Dario Ferrero, Chiara Frairia, Antonella Vaccarino, Davide Griguolo, Stefania Paolini, Martina Quintini, Mariarosaria Sessa, Mauro Turrini, Monica Bocchia, Nicola Di Renzo, Elisa Diral, Cristina Foli, Alfredo Molteni, Ubaldo Occhini, Giulia Rivoli, Carmine Selleri, Roberto Bono, Anna Calvisi, Andrea Castelli, Eros Di Bona, Ambra Di Veroli, Luana Fianchi, Sara Galimberti, Daniele Grimaldi, Monia Marchetti, Marianna Norata, Alessandro Rambaldi, Ilaria Tanasi, Patrizia Tosi, Ilaria Naldi, Valeria Santini, Matteo G. Della Porta
Journal: Blood (2022)
Measures of Structural Racism Predict ICU Admission Following Intensive Chemotherapy for AML
Authors: Ivy Abraham, Garth Rauscher, Anand Ashwin Patel, Sarah Monick, Madelyn Burkhart, Eshana Shah, Ami Dave, Matthew Kroll, Stephanie B. Tsai, Stephanie Berg, Amani Erra, Vedavyas Gannamani, Maryam Zia, Melissa L. Larson, Wendy Stock, Jessica K. Altman, Irum Khan
Journal: Blood (2022)
Different Subsets of Exhausted and Senescent-like T Cells Correlate with Response and Survival in Patients with Acute Myeloid Leukemia (AML) Undergoing Chemotherapy
Authors: Francesco Mazziotta, Luca Biavati, Sonali Parbhoo, Sayan Chowdhury, Joseph Rimando, Ivan M. Borrello, Katerina Hatzi, Bruce R. Blazar, Ivana Gojo, Leo Luznik
Journal: Blood (2022)
Changes in Symptoms, Function, and Quality of Life in Older Adults with Acute Myeloid Leukemia Treated with Venetoclax and Hypomethylating Agents
Authors: Ya-Ning Chan, Daniel R. Richardson, Courtney Berry, Stephanie Betancur, Hayden Michael Dumaw, Todd Schwartz, Mackenzi Pergolotti, Susan Coppola, Christopher Jensen, Matthew C. Foster, Ashley L. Bryant
Journal: Blood (2022)
Endothelial Cells Activate Alloreactive CD4+ T Cells to Initiate Acute Graft-<i>Versus</i>-Host Disease
Authors: Haroon Shaikh, Juan Gamboa Vargas, Zeinab Mokhtari, Josefina Peña Mosca, Joern Pezoldt, Hermann Einsele, Jochen Huehn, Andreas Beilhack
Journal: Blood (2022)
Targeting HDAC3 to Overcome the Resistance to ATRA or Arsenic in Acute Promyelocytic Leukemia through Ubiquitination and Degradation of PML-RARα
Authors: Bo Dai, Feng Wang, Ying Wang, Jiayan Zhu, Yunxuan Li, Tingting Zhang, Luyao Zhao, Li-Ling Wang, Wenhui GAO, Junmin Li, Aibin Liang, Hong-hu Zhu, Ke Li, Jiong Hu
Journal: Blood (2022)
Rare Deleterious <i>TCF3</i> Germline Variants and Predisposition to Acute Lymphoblastic Leukemia in Children
Authors: Carolin Escherich, Wenan Chen, Satoshi Miyamoto, Yui Namikawa, Wenjian Yang, David T. Teachey, Zhenhua Li, Elizabeth A. Raetz, Eric C Larsen, Meenakshi Devidas, Paul L. Martin, W Paul Bowman, Gang Wu, Ching-Hon Pui, Stephen P. Hunger, Masatoshi Takagi, Jun J. Yang, Mignon L. Loh
Journal: Blood (2022)
Autoimmune Hemolytic Anemia during Pregnancy or Post-Partum: An International Multi-Center Experience
Authors: Marta Bortolotti, Norma Fantini, Andreas Glenthøj, Marc Michel, Mariasanta Napolitano, Simona Raso, Frederick Chen, Vickie McDonald, Irina Murakhovskaya, Josephine M.I. Vos, Andrea Patriarca, Maria Eva Mingot, Giulio Giordano, Margherita Scarrone, Laura Trespidi, Daniele Prati, Wilma Barcellini, Bruno Fattizzo
Journal: Blood (2022)
Treatment Patterns and Patient Outcomes in Relapsed/Refractory Multiple Myeloma (RRMM) Stratified By Exposure to Lenalidomide or Anti-CD38 Therapy and Double-Class Refractory Status: A Retrospective Electronic Health Record Database Study
Authors: Joshua Richter, Peter Feng Wang, Alexa Molinari, Boris Gorsh, Natalie Boytsov, Suzanne Landi, Sue Perera, Prani Paka, Teresa Palumbo, Mei Sheng Duh, Christopher Yee, Anamika Khanal, Sonia Gupta, Ajai Chari
Journal: Blood (2022)
The Easix Score Predicts Overall Survival and Late Relapse in Patients Undergoing Reduced Intensity Conditioned Allogeneic Stem Cell Transplantation for Myeloid Disease
Authors: Chris Armstrong, Eibhlin Conneally, Catherine M Flynn, Nicola Gardiner, Hayley Foy-Stones, Aidan Kelly, Mairead Ni Chonghaile, Nina Orfali
Journal: Blood (2022)
Prognostic Relevance of Adult Acute Myeloid Leukemia Patients According to the 2022 European Leukemianet Risk Stratiﬁcation
Authors: Min Yen Lo, Cheng-Hong Tsai, Yuan-Yeh Kuo, Mei-Hsuan Tseng, Yen-Ling Peng, Cheng-An Hsu, Hsun-I Sun, Yi-Kuang Chuang, Wen-Chien Chou, Hsin-An Hou, Hwei-Fang Tien
Journal: Blood (2022)
High Incidence of Intra-Cardiac Supra-Centimetric Thrombosis and Embolic Complications in Sickle Cell Disease Patients with Dual Lumen Ports
Authors: Camille Roussel, Sandra Manceau, Zeynep Cacan, Celine Gounou, Laurent Sabbah, Alain Brisson, Lucie Dumas, Delphine Borgel, Laure Joseph
Journal: Blood (2022)
Long-Term Adverse Events of Total Marrow Irradiation (TMI)-Based Conditioning Chemotherapy in Hematopoietic Stem Cell Transplant Recipients Treated on a Phase I/II Trial
Authors: Lucas Maahs, Pritesh Patel, Karen Sweiss, Chukwuemeka Uzoka, Nadim Mahmud, Ana Maria Avila, Matthew Koshy, Damiano Rondelli
Journal: Blood (2022)
Clinical Outcomes of Patients with <i>TP53</i>-Mutated AML after First Relapse or with Primary Refractory Disease: Results from Consortium on Myeloid Malignancies and Neoplastic Diseases (COMMAND)
Authors: Talha Badar, Ehab L. Atallah, Antoine N. Saliba, Rory Michael Shallis, Maximilian F. Stahl, Jan Philipp Bewersdorf, Guillerhme Sacchi De Camargo Correia, Anand Ashwin Patel, Yasmin Abaza, Guru Subramanian Guru Murthy, Adam S Duvall, Madelyn Burkart, Neil Palmisiano, Danielle Bradshaw, Vamsi K. Kota, Shira Dinner, Aaron D Goldberg, Mark R. Litzow
Journal: Blood (2022)
Synergistic Effect of Low-Dose Cyclosporine a on Eltrombopag (EPAG) in the Management of Prior Epag and Multiline Failed Immune Thrombocytopenia Patients: A Single-Center, Self-Control Study
Authors: Yilei Hong, Yingying Shen, Qi Liu, Jingjie Dong, Jingjing Xiang, Wenbin Liu, Yiping Shen, Liqiang Wu, Yuhong Zhou, Baodong Ye, Dijiong Wu
Journal: Blood (2022)
Final Analysis of JCOG0203 for Advanced-Stage Indolent B-Cell Lymphoma 15 Years after the End of Enrollment: Pooled Analysis of Arms a and B for Follicular Lymphoma
Authors: Takashi Watanabe, Kensei Tobinai, Ｍasashi Wakabayashi, Dai Maruyama, Kazuhito Yamamoto, Nobuko Kubota, Kazuyuki Shimada, Kohsuke Asagoe, Motoko Yamaguchi, Kiyoshi Ando, Michinori Ogura, Junya Kuroda, Youko Suehiro, Yoshihiro Matsuno, Kunihiro Tsukasaki, Hirokazu Nagai
Journal: Blood (2022)
Pregnancy Surveillance in Sickle Cell Disease Patients: A Cohort Study in an African Country - Angola
Authors: Miguel Brito, Catarina Ginete, Joana Ferreira, Manuela Mendes, Jocelyne Vasconcelos, Mariana Delgadinho, Cruz Santos, Francisco Quinto, Fernanda Simão, Anabela Mateus, Filipe Fernandes
Journal: Blood (2022)
Allogeneic CAR-NK Cell Therapy Targeting Both BCMA and GPRC5D for the Treatment of Multiple Myeloma
Authors: Zhuoxiao Cao, Cuiqing Yang, Yifang Wang, Chao Wang, Qingyang Wang, Gang Ye, Tingting Liu, Qin Wang, Huanyu Wang, Yanxue Gong, Biye Wang, Fuwei Jiang
Journal: Blood (2022)
Wnt and Notch Pathways Regulate Stemness of Myeloid Leukemia Cells Via IL33/ST2 Signaling
Authors: Pascal Naef, Ramin Radpour, Carla Jaeger-Ruckstuhl, Nils Bodmer, Gabriela M Baerlocher, Hartmut Döhner, Konstanze Döhner, Carsten Riether, Adrian Ochsenbein
Journal: Blood (2022)
Oncogene EVI1 Drives Acute Myeloid Leukemia Via a Targetable EVI1-CtBP1/2 Interaction and By Repressing Myeloid Regulator <i>CEBPA</i>
Authors: Dorien Pastoors, Marije Havermans, Remco Hoogenboezem, Roger Mulet-Lazaro, Duncan Brian, Leonie Smeenk, Claudia Erpelinck-Verschueren, Stanley van Herk, Bas Wouters, Jeroen A.A. Demmers, Johannes Zuber, Tariq Enver, Richard WJ Groen, Eric Bindels, Ruud Delwel
Journal: Blood (2022)
Evorpacept (ALX148), a CD47-Blocking Myeloid Checkpoint Inhibitor, in Combination with Azacitidine and Venetoclax in Patients with Acute Myeloid Leukemia (ASPEN-05): Results from Phase 1a Dose Escalation Part
Authors: Guillermo Garcia-Manero, Amanda Przespolewski, Yasmin Abaza, Michael Byrne, Abraham P. Fong, Feng Jin, Alison J. Forgie, Athanasios C. Tsiatis, Shanhong Guan, Harry P. Erba
Journal: Blood (2022)
Venous Thromboembolism Risk in Cancer Patients Receiving First-Line Immune Checkpoint Inhibitor Vs. Chemotherapy
Authors: Sarah B May, Jennifer La, Emily Milner, Nimrah Riaz, Christopher I Amos, David A. Garcia, Marc Carrier, Neil Zakai, Nhan V Do, Mary Brophy, Vipul Chitalia, J. Michael Gaziano, Nathanael Fillmore, Ang Li
Journal: Blood (2022)
Prospective Study of Complement Activation with Functional and Genetic Assays in Sickle Cell Disease
Authors: Christos Varelas, Efthymia Vlachaki, Filippos Klonizakis, Despoina Pantelidou, Fani Minti, Michael D. Diamantidis, Nikolaos Sampanis, Ioanna Giatagantzidou, Despoina Papadopoulou, Evdoxia Koravou, Ioanna Christodoulou, Evaggelia Zarkada, Tasoula Touloumenidou, Apostolia Papalexandri, Ioanna Sakellari, George Vassilopoulos, Robert Brodsky, Eleni Gavriilaki
Journal: Blood (2022)
Clinical and Molecular Profiling of AML Patients with Chromosome 7 or 7q Deletions Incontext of <i>TP53</i> Alterations and Venetoclax Treatment
Authors: Hussein A Abbas, Edward Ayoub, Hanxiao Sun, Rashmi Kanagal-Shamanna, Nicholas Short, Ghayas C. Issa, Musa Yilmaz, Sherry A. Pierce, Daniel Rivera, Brent Cham, Shane Wing, Ziyi Li, Danielle Hammond, Elias Jabbour, Gautam Borthakur, Guillermo Garcia-Manero, Michael Andreeff, Naval Daver, Tapan M. Kadia, Marina Konopleva, Courtney D. DiNardo, Farhad Ravandi
Journal: Blood (2022)
Basiliximab in the Prevention of aGVHD for Unrelated Donor Hematopoietic Stem Cell Transplantation in Patients with Thalassemia Major: A Prospective, Multicenter, Open-Label, Randomized Controlled Study
Authors: Rongrong Liu, Meiqing Wu, Qiaochuan Li, Lianjin Liu, Chunjie Qin, Hong Chen, Lingling Shi, Gaohui Yang, Zeyan Shi, Zhongqing Li, Zhenbin Wei, Beicai Liu, Jing Fan, Yinghua Chen, Xuemei Zhou, Zhongming Zhang, Yongrong Lai, Qifa Liu
Journal: Blood (2022)
Impaired Metabolic Plasticity Under Stress Constitutes a Therapeutic Vulnerability in <i>IDH1/2</i>-Mutant Acute Myeloid Leukemia
Authors: Dominique Sternadt, Diego Pereira-Martins, Douglas RA Silveira, Prodromos Chatzikyriakou, Maria del Pilar Casares Alaez, Isabel Weinhaeuser, Shanna M Hogeling, Emanuele Ammatuna, Gerwin A. Huls, Lynn Quek, Jan Jacob Schuringa
Journal: Blood (2022)
Preclinical Characterization of NGM936, a Novel Bispecific T Cell Engager Targeting ILT3 for the Treatment of Acute Myeloid Leukemia with Monocytic Differentiation
Authors: Vicky Y Lin, Anjushree Iyer, Keith Akama, Rujin Cheng, Hong Yang, Jonathan Aguayo, Betty Li, Alan K Kutach, Jie Tang, Daniel Kaplan, Julie M Roda
Journal: Blood (2022)
Prognostic Impact of Measurable Residual Clonal Hematopoiesis after Allogeneic Stem Cell Transplantation in Patients with Acute Myeloid Leukemia
Authors: Lara Bischof, Elizabeth Gaston, Jule Ussmann, Juliane Grimm, Marius Bill, Dominic Brauer, Donata Backhaus, Lisa Herrmann, Maximilian Merz, Marco Herling, Klaus H. Metzeler, Georg-Nikolaus Franke, Vladan Vucinic, Uwe Platzbecker, Sebastian Schwind, Madlen Jentzsch
Journal: Blood (2022)